ABVC BIOPHARMA INC (ABVC) Stock Cash Flow
NASDAQ:ABVC - Nasdaq - US00091F3047 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -2.22M | -5.26M | -10.91M | -16.31M | -12.04M | |||
| Depreciation Amortization | 37.70K | 32.00K | 28.50K | 20.00K | 10.00K | |||
| Income Taxes - Deferred | N/A | 0.00 | 115.70K | 860.00K | 820.00K | |||
| Change In Working Capital | -718.90K | -410.00K | 422.30K | 640.00K | -1.61M | |||
| Interest Paid | 22.00K | 22.50K | 33.20K | 290.00K | 330.00K | |||
| Taxes Paid | N/A | 25.90K | 27.40K | 0.00 | 0.00 | |||
| Other non cash items | 1.03M | 3.83M | 3.53M | 7.39M | 5.22M | |||
| OPERATING CASH FLOW | -1.88M | -1.81M | -4.19M | -7.40M | -7.60M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -21.20K | -120.00K | -20.00K | |||
| Other Investing Activity | N/A | 0.00 | -339.00K | -1.60M | -790.00K | |||
| INVESTING CASH FLOW | N/A | 0.00 | -360.20K | -1.72M | -810.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -279.10K | -14.10K | 462.60K | 350.00K | -270.00K | |||
| Stock Issued/Repurchased | 1.38M | 1.37M | 3.46M | 3.66M | 11.12M | |||
| Other Financing Activity | N/A | 629.60K | -49.00K | 0.00 | -850.00K | |||
| FINANCING CASH FLOW | 1.73M | 1.98M | 3.87M | 4.01M | 10.00M | |||
| Exchange Rate Effect | 243.00K | -24.60K | 2.10K | -70.00K | -30.00K | |||
| CHANGE IN CASH | 100.60K | 147.00K | -675.00K | -5.18M | 1.56M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -1.88M | -1.81M | -4.19M | -7.40M | -7.60M | |||
| Capital Expenditure | N/A | 0.00 | -21.20K | -120.00K | -20.00K | |||
| FREE CASH FLOW | -1.88M | -1.81M | -4.21M | -7.52M | -7.62M | |||
All data in USD